Skip to content

Clinical trials

Seizures trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20101
20122
20132
20152
20161
20172
20184
20192
20201
20213
20222
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status6
Recruiting5
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Fudan University4
Longboard Pharmaceuticals3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Eisai Inc.2
Affiliated Hospital of Jiangnan University1
Beijing Tiantan Hospital1
Eisai Co., Ltd.1
Epygenix1
Jiangxi Qingfeng Pharmaceutical Co. Ltd.1
Liu Yonghong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures30
Epilepsy21
Lennox Gastaut Syndrome4
Epilepsies, Myoclonic3
Neurodevelopmental Disorders3
Tuberous Sclerosis2
Angioedema1
Apnea1
Autoimmune Diseases of the Nervous System1
Blood Loss, Surgical1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.